Characterizing protein kinase substrate specificity motifs represents a powerful step in elucidating kinase-signaling cascades. The protocol described here uses a bacterial system to evaluate kinase specificity motifs in vivo, without the need for radioactive ATP. The human kinase of interest is cloned into a heterologous bacterial expression vector and allowed to phosphorylate E. coli proteins in vivo, consistent with its endogenous substrate preferences. The cells are lysed, and the bacterial proteins are digested into peptides and phosphoenriched using bulk TiO 2 . The pooled phosphopeptides are identified by tandem mass spectrometry, and bioinformatically analyzed using the pLogo visualization tool. The ProPeL approach allows for detailed characterization of wildtype kinase specificity motifs, identification of specificity drift due to kinase mutations, and evaluation of kinase residue structure-function relationships. C 2018 by John Wiley & Sons, Inc.
INTRODUCTION
Protein kinases are enzymes that catalyze the covalent addition of phosphate to specific amino acids within protein substrates as post-translational modifications. Such alter can often alter the biological function of the target protein, so understanding the relationship between kinases and their substrates can provide important biological insights. However, traditional co-immunoprecipitation methods do not work to identify these transient interactions, so alternative approaches including the one described here have been developed.
Kinases discriminate their substrates, in part, by recognizing short linear patterns of amino acids or "motifs" that surround the phosphoacceptor residue (Pinna & Ruzzene, 1996; Ubersax and Ferrell Jr, 2007) , and the identification of these motifs has proven to be a powerful tool for substrate hypothesis generation (Miller et al., 2008; Obenauer, Cantley, & Yaffe, 2003) . This unit presents a non-radioactive, bacterial approach for querying protein kinase substrate specificity in vivo termed ProPeL (for Proteomic Peptide Library, Chou et al., 2012) . In this method, a human kinase is expressed in E. coli cells (which have a very low background level of endogenous phosphorylation). The bacterial proteome functions as a substrate library for the human kinase to phosphorylate in vivo, consistent with its distinct specificity. In this way, the E. coli acts as a living mini reaction vessel, facilitating thousands of simultaneous in vivo phosphorylation events and generating thousands of kinase-specific phosphorylation sites that are isolated and identified by liquid chromatography tandem mass spectrometry (LC-MS/MS). Using our laboratory's suite of computational tools, we can extract and visualize kinase specificity motifs, and make high-confidence predictions of downstream targets. ProPeL can also be used to evaluate the influence of disease-associated mutations on kinase substrate specificity (Lubner et al., 2017) .
The Basic Protocol describes the overall ProPeL workflow, which is represented in Figure 1 . The major steps include expression of the kinase of interest and in vivo phosphorylation of bacterial proteins, tryptic digestion, phosphopeptide enrichment, phosphopeptide identification by LC-MS/MS, and computational analysis. Prior to carrying out ProPeL, the kinase of interest must be cloned into an appropriate bacterial expression vector (Strategic Planning), and in vivo activity may need to be optimized (Troubleshooting). In the event that the kinase cannot be expressed in an active form in E. coli, it is possible to perform an in vitro version of ProPeL using recombinant (or endogenously purified) kinase (Alternate Protocol).
STRATEGIC PLANNING
At the start of a new ProPeL project, it is important to design the correct kinase insert, and choose an appropriate bacterial expression vector. A successful ProPeL experiment necessarily requires the expression of a soluble, constitutively active protein kinase. This may require expressing a truncation that omits inhibitory sequences (such as the Cterminal PKC inhibitory tail) or mimics caspase cleavage (as is required for full activation of MST3). In other instances, it is as simple as expressing the naked catalytic subunit, as Desalting wash solution C (see recipe) Titansphere TiO 2 5 µm beads (GL Sciences, cat. no. 1400B500)
Sterile pipette tips Shaking bacterial culture incubator 500-ml Erlenmeyer flasks Refrigerated centrifuge Probe sonicator 5-ml disposable sterile syringe with Luer Lock (Fisher Scientific cat. no. 14-829-45) 0.22-μm sterile syringe filters (Fisher Scientific cat. no. SLGL0250S) Room temperature 15-ml conical tube shaker Electrophoresis chamber Gel imager Vortex mixer 15-ml conical tubes tC18 SEP-Pak cartridges (Waters, cat. no. WAT054925) 1.5-ml microcentrifuge tubes SpeedVac Empore SPE Disks C18 (Sigma-Aldrich, cat. no. 66883-U) Kel-F hub (KF), point style 3, gauge 16 needle (Hamilton Company, cat. no. 90516) Plunger assembly N, RN, LT, LTN for model 1702 (Hamilton Company, cat. no.
1122-01)
NOTE: The authors believe that overexpression of a kinase-dead mutant is a better negative control than either an un-induced culture, or induction with an empty vector. The negative control kinase will more closely mimic the cellular stress of heterologous protein overexpression, and does not pose the contamination risk that may be encountered as a result of leaky expression of an active kinase.
Kinase expression and in vivo phosphorylation of bacterial proteins
This protocol assumes that the appropriate kinase-coding sequence has been cloned into a bacterial expression vector, and transformed into an appropriate E. coli cell strain. The following steps are for standard protein expression using an IPTG-inducible vector. Optimal protein expression conditions need to be determined empirically, and the expression steps should be adjusted accordingly.
1. Using a sterile pipette tip, streak a fresh LB agar plate (+ appropriate antibiotic) from a bacterial glycerol stock. Incubate plate upside down overnight at 37°C.
7. Prepare lysis buffer, add at 5 ml/g of wet pellet, and resuspend by pipet mixing.
8. Lyse cells by sonication, using 15-sec pulses on 15% power, until solution is no longer opaque. 12. For each sample, separate 25 μg (or 75 μg if using NanoDrop A280 measurement) by SDS-PAGE, with 2 μl PeppermintStick Phosphoprotein ladder (and 5 μl All Blue Protein Standards, optional).
Stain the gel
Analyze with Pro-Q Diamond stain as described below, according to manufacturer's instructions. All incubations should be carried out on a rocker at room temperature.
13. Immerse the gel in 100 ml fix solution and incubate for 30 min. Discard the fix solution and add100 ml fresh fix solution. Incubate for at least 30 min.
This is a pause point, as gel can be left in fix solution overnight. Figure 2 For the attached replacement figure, please scale the image to the maximum size to aid in clarity. Also, note that this is a new image, and is therefore no longer a modification of the previous publication Lubner et al. 2016 18. Add 20 ml GelCode Blue and incubate on a rocker at room temperature for at least an hour. Preferably, leave the gel overnight in GelCode Blue for clearest signal.
19. Destain using ultrapure water. For best results, change water several times until background signal has been completely removed. Gel may be left in water overnight.
20. Image using the Coomassie setting (and white light conversion screen). 24. Resuspend the pellet in sufficient lysis buffer, quantify by BCA, and adjust with additional lysis buffer to obtain 1 ml sample at a final protein concentration of 10 mg/ml. Pipet mixing can be aided by gently vortexing the sample and using heat for short durations (do not exceed 50°C). Sample can also be allowed to resolubilize overnight at 4°C for best results.
Heating the sample to 50°C (step 24) 28. Transfer the sample into a 15-ml conical tube, and dilute the sample 1:5 by adding 4.2 ml of 25 mM Tris·Cl (pH 8.2), to reduce urea concentration from 8 M to 1.6 M.
29. Add CaCl 2 from a 0.1 M stock to a final concentration of 1 mM (53 μl of 0.1 M CaCl 2 ).
30. Add 100 µg trypsin (for an enzyme:substrate ratio of 1:100), and incubate for 16 hr at 37°C.
31. Allow the digest to cool to room temperature, and stop digestion by acidification with 25 μl trifluoracetic acid to 0.4% (v/v) . Verify that pH <2.5, otherwise, add additional trifluoracetic acid. Centrifuge for 10 min at 2500 × g, room temperature, and transfer the supernatant into a fresh 15-ml conical tube. 33. Condition the cartridge using 6 ml of acetonitrile followed by 2 ml of desalting elution solution.
34. Equilibrate with 6 ml of desalting wash solution A.
35. Load the sample from step 31.
36. Wash/desalt with 6 ml of desalting wash solution A.
37. Wash with 500 μl desalting wash solution B.
38. Elute into a clean 1.5-ml tube with 1 ml desalting elution solution.
39. Measure protein concentration by NanoDrop A280 (or other protein estimation method) and determine total quantity of protein in sample. Transfer 4 mg of peptides into a clean 1.5-ml tube.
40. Snap-freeze with liquid nitrogen and SpeedVac until the sample is a white (sometimes yellowish) pellet.
Avoid over-drying pellet, as this will make it very difficult to resuspend. Samples can be stored up to 1 year at −20°C if TiO 2 phosphoenrichment cannot be performed immediately, but for best results proceed immediately to the next step.
Combined TiO 2 phosphoenrichment and terminal desalting Phosphopeptides will be isolated by bulk TiO 2 enrichment. Combining the TiO 2 and terminal desalting steps helps to prevent loss and/or carryover of beads. Commercial desalting tips may be purchased (Thermo Fisher Scientific cat. no. PI89873); however, we routinely prepare StageTips in-house using five C18 plugs packed gently into a 200-μl tip, according to Rappsilber, Mann, & Ishihama, 2007 . StageTips should be prepared during the TiO 2 incubation.
41. Prepare the following solutions: TiO 2 binding solution, TiO 2 elution solution B, desalting wash solution C, and desalting elution solution.
42. Add 1 ml TiO 2 binding solution to dried down peptides and allow to resolubilize for >30 min. Transfer into 15-ml conical tube and add an additional 2.6 ml TiO 2 binding solution (final volume 3.6 ml TiO 2 binding solution).
Due to the lactic acid, the TiO 2 binding solution can result in gloves becoming sticky. Gloves exposed to TiO 2 binding solution may stick to tubes.
Lubner et al.
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Current Protocols in Chemical Biology 43. Condition enough TiO 2 beads to allow for a 1:1 ratio of beads to peptides based on post-SEP-Pak NanoDrop reading (e.g., 4 mg beads for every 4 mg peptides). 47. To bind phosphopeptides, incubate in a conical tube shaker at maximum speed for 1 hr at room temperature.
48. Pellet the beads by centrifugation for 30 sec at 600 × g, room temperature, and remove the supernatant. Be careful not to remove beads. Binding buffer supernatant and all subsequent washes may be saved as "non-phosphopeptides" for analysis, if desired.
49. Wash the beads with 1 ml TiO 2 binding solution.
50. Pellet the beads and remove the supernatant. Repeat the wash two more times with fresh TiO 2 binding solution for a total of three washes. 58. Wash with 100 μl desalting wash buffer C.
Resuspend the beads in 200 μl
59. Elute phosphopeptides off the disc with 100 μl desalting elution solution.
60. Dry the eluent in a SpeedVac, and store up to 1 year at −20°C until analysis by LC-MS/MS (see Support Protocol 1 for mass spectrometry acquisition and analysis procedures).
Phosphopeptide list creation and filtering
Prior to motif visualization, mass spectrometry data must be filtered for appropriate sequences and converted into a set of phosphorylation-centered 15mers. This is accomplished by removing undesirable peptide matches within the Phospho(STY) modificationspecific file, and bioinformatically determining the in vivo 15-residue context centered around the phosphoacceptor.
61. Within the Phospho(STY) modification-specific file, remove any peptides that match to a reverse database, or are identified as a contaminant.
62. If additionally searching against the human proteome, remove any autophosphorylation sites on the kinase of interest. 63. Filter phosphopeptides to only retain high-confidence sites with a localization probability of ࣙ0.9. This is most easily accomplished by a text find-and-replace where "(1)" and "(0.9" are replaced with "*". (Chou & Schwartz, 2011; Schwartz & Gygi, 2005 64. Paste the peptide sequences into the input box in the top left corner of the PeptidExtender Web page. This will cause "modification markers" to populate. Select "*" as the modification marker, select "right of modified residue" for position, and enter a target sequence width of 15. Select the "E. coli" proteome as the extension database. Click "extend peptides!" to create a list of unique phosphorylation-centered 15mers.
Note that this localization probability value is based on the software detailed in Support Protocol 1. If a different search algorithm is used (or parameters are changed), this value may need to be determined empirically. Each site must be converted to a modification-centered 15mer; therefore, any phosphorylation site that is too close to a protein terminus to be extended to a centered 15mer is discarded. This is the same procedure as in motif-x analyses

PeptidExtender automatically filters out non-selected potential markers (e.g., non-amino acid characters such as numbers and brackets), deletes redundant sequences, and removes any sequence that fails to generate a full 15mer. The output from PeptidExtender is correctly formatted to be directly pasted into pLogo, although additional negative-control subtraction is necessary prior to motif visualization.
It is critical to remove endogenous E. coli phosphorylation sites from the foreground data set. We have curated a master negative control list (Lubner et al., 2017) , which was generated by pooling phosphopeptides previously identified in negative control experiments (Chou et al., 2012) , previously identified endogenous E. coli phosphorylation sites (Macek et al., 2008; Soares et al., 2013) , sites identified in Hansen et al., 2013, and Potel et al., 2018, and  
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(redundant sites will be automatically removed by our software). These final data sets can be used for motif visualization by pLogo (see Support Protocol 2) or motif analysis by motif-x (Chou & Schwartz, 2011; Schwartz & Gygi, 2005) .
ALTERNATE PROTOCOL IN VITRO KINASE REACTION
As mentioned above, there are several challenges associated with heterologous kinase expression in E. coli. However, many of the positive features of ProPeL are retained in an in vitro version of the protocol. Conceptually, the issues of kinase expression and/or activation are solved through purification of recombinant or endogenous kinase from an alternative source, and activation with the required co-factors. By adding recombinant kinase to E. coli lysate in a traditional in vitro kinase reaction, the target kinase is still able to phosphorylate bacterial proteins, which can be isolated as in the standard ProPeL workflow. This format still allows the high signal to noise ratio and direct link afforded by the low endogenous E. coli serine/threonine/tyrosine phosphorylation, and reactions still take place with full-length protein substrates. Identification by LC-MS/MS is the same, allowing high throughput identification, and the preservation of intra-motif correlations due to the proteomic context of each phosphopeptide.
There are a few different options for producing recombinant kinase. The target kinase can still be expressed in E. coli, and then affinity purified. This would be most useful in the case of re-constituting a kinase cascade, where the individual kinases can be purified separately by using distinct affinity tags. Alternatively, other host systems such as yeast, insect, or human cells may be employed to produce recombinant kinase. Finally, the use of cell-free protein systems allow for production of post-translationally modified kinases without the need for cell culture (Oza et al., 2015) . Optimal kinase reaction conditions need to be determined empirically.
Additional Materials (also see Basic Protocol)
Untransformed or empty vector E. coli bacterial stock Recombinant Kinase (purchase or purify in-house) Appropriate Kinase Reaction Buffer (determine empirically) Adenosine 5 -triphosphate (ATP) (Fisher Scientific cat. no. BP413-25)
Preparation of bacterial substrate library For the in vitro version of ProPeL, bacterial proteins still function as a substrate library. Using either an untransformed bacterial stock or an empty vector stock, cells are grown and harvested similarly to the Basic Protocol, but lysed in kinase reaction buffer.
1. Using a sterile pipette tip, streak a fresh LB agar plate (+ appropriate antibiotic) from a bacterial glycerol stock. Incubate the plate upside down overnight at 37°C.
2. Inoculate a well-isolated colony in 5 ml LB medium (+ appropriate antibiotic) and grow overnight at 37°C and 250 rpm.
3. Inoculate 100 ml LB medium (+ appropriate antibiotic) with 2 ml of overnight culture in a 500-ml Erlenmeyer flask.
4. Optional: Grow bacteria to an OD 600 of 0.4-0.6 (mid-log) and induce with 0.5 mM IPTG.
5. Incubate for 3 to 24 hr at 37°C and 250 rpm.
6. Pellet the cells by centrifugation for 15 min at 6000 × g, 4°C.
7. Pellet may be stored up to 1 year at −80°C, but it is best to proceed promptly. 12. Quantify the samples by BCA assay.
Lubner et al.
When preparing sample for LC-MS/MS, use all LC/MS grade solvents and Eppendorf
In vitro kinase reaction and evaluation of kinase activity
In this protocol, recombinant kinase is incubated with bacterial lysate in an in vitro kinase reaction. Optimal reaction conditions should be determined empirically using small-scale reactions before proceeding to the full 10 mg reaction. After this section, sample preparation for LC-MS/MS is resumed as in the Basic Protocol.
13. Transfer 10 mg bacterial lysate into a 1.5-ml tube.
14. Add appropriate volume recombinant kinase and 1× kinase reaction buffer, and incubate 3 hr at 30°C. 18. Discard the fix solution and wash with 100 ml ultrapure water. Incubate for 10 min, discard, and repeat twice for a total of three water washes.
All subsequent incubations must be done in the dark, as Pro-Q Diamond is light sensitive.
19. Add 60 ml Pro-Q Diamond stain and incubate for 90 min.
20. Discard stain and add 90 ml Pro-Q Diamond destain solution, incubating for 30 min. Discard destain and repeat twice more for a total of three destain washes. Rinse with 100 ml ultrapure water for 5 min, discard, and repeat water wash once.
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PHOSPHOPEPTIDE IDENTIFICATION BY LIQUID CHROMATOGRAPHY-TANDEM MASS SPECTROMETRY
The following protocol represents our current instrumentation, and is provided as a reference.
Materials
Q Exactive HF Orbitrap mass spectrometer (Thermo Scientific) Ultimate 3000 RSLC (Thermo Scientific) 250-mm nanoEase M/Z peptide BEH C18 column 130Å, 1.7 µm particle size, 75 µm i.d (Waters, cat. no. 186008795) 10-µm silica PicoTip emitter (New Objective, cat. no. FS360-20-10-N-20-C12)
Liquid chromatography and mass spectrometry analysis Dried and enriched phosphopeptides are resuspended in 40 µl of 0.1% formic acid in water. Peptide identification is achieved using electrospray ionization (ESI) and nanoLC-MS/MS on a Q Exactive HF Orbitrap mass spectrometer (QE-HF) coupled to an Ultimate 3000 RSLC operated in nanoflow mode. A 250-mm nanoEase M/Z peptide BEH C18 column is fitted to a 10-µm silica PicoTip emitter to permit ESI directly into the QE-HF inlet. For all samples, 1 µl is loaded and subject to a 150 min, 300 nl/min linear reversed-phase gradient (Solvent A: 0.1% formic acid in water, Solvent B: 0.1% formic acid in acetonitrile) as follows: initial 4% solvent B hold for 10 min, increase to 30% solvent B over 90 min, increase to 90% solvent B over 20 min, 90% solvent B hold for 10 min, then decrease to 4% solvent B over 2 min, followed by a re-equilibration period for 18 min. Column temperature is set to 50°C for the entire gradient. The QE-HF is operated in positive ion mode with a spray voltage of 1.5 kV. The capillary temperature is set to 250°C and all source gas flows are turned off. A Top 15 datadependent (dd) MS/MS method is used that implements the following parameters for full MS scans: 1 microscan, 60,000 resolution at 200 m/z, 1e6 AGC target, 60 msec max ion time, and 300 to 1800 m/z mass range. MS/MS scans are acquired with the following parameters: 15,000 resolution at 20 m/z, 1e5 AGC target, 40 msec max IT time, 2.0 m/z isolation window, 0 m/z isolation offset, 200 to 2000 m/z mass range, 27 normalized collision energy, peptide match "preferred," exclude isotopes "on," a 30 sec dynamic exclusion window, and charge state exclusion set to exclude +1 and >+8 ions. All spectral data are collected in profile mode. A QC analysis of tryptic BSA peptides (optional) is analyzed between each ProPeL injection to minimize sample carryover and gauge instrument performance stability. Similar instrument parameters are used but a shorter, 60 min gradient is performed in place of the 120 min gradient previously described.
Phosphopeptide identification and site localization
Raw files are searched with the Andromeda search engine and MaxQuant (Cox & Mann, 2008) against the UniProt E. coli strain B/BL21-DE3 proteome database (Proteome ID UP000002032). A reversed E. coli protein sequence database is automatically generated by the software and searched concurrently. All searches include the following parameters: 4.5 and 20 ppm mass tolerances for precursor and fragment ions, respectively, trypsin enzyme specificity, up to 2 missed cleavages, fixed carbamidomethyl C modification, variable phosphorylation of serine/threonine/tyrosine, oxidation of methionine, and acetylation of protein N-termini. Minimum peptide length is set to 5 and the contaminant database is included. All results are filtered at a 1% false discovery rate at the peptide spectrum match, protein and site levels. All other parameters are kept at MaxQuant default settings (version 1.6.0.1 at time of publication).
SUPPORT PROTOCOL 2
MOTIF VISUALIZATION WITH PLOGO
pLogos (O'Shea et al., 2013) depict residues proportional to the log-odds of their binomial probabilities with respect to a given background. In a pLogo, the most statistically significant residues appear closest to the x-axis, with residues above the x-axis indicating overrepresentation and those below the x-axis indicating underrepresentation. Given the existence of one or more different residues at a given substrate position, it is possible to compute conditional probabilities of all remaining amino acids and positions to determine significant positions given specific residues at specific positions. We refer to this as "fixing" a given residue at a given position, which allows for the exploration of correlated or uncorrelated residues across positions in the kinase specificity motif. Fixed positions within the pLogo (e.g., the central position) are depicted on a grey background, and red horizontal lines denote the p = 0.05 significance threshold (after Bonferroni correction). pLogos can be scaled for clarity. For each pLogo, the foreground data is the list of phosphorylation-centered 15mers, with negative control sites removed. The E. coli background data set is generated by pLogo through alignment of all unique phosphoacceptor-centered 15mers in the E. coli proteome. Below are basic instructions for generating pLogos.
1. Access the pLogo Web site (and register for an account if desired): https://plogo. uconn.edu 2. Paste desired foreground data set of aligned 15mers into the box on the left of the page.
3. Select "Protein" and then "e. coli k12" from the available backgrounds on the right of the page.
Optional:
If logged into a personal account, the user may add a job name.
5. Click the "generate pLogo" button in the center of the page.
6. Residues can be fixed or unfixed by clicking on them; however, residues that do not achieve statistical significance may not be fixed. Alternatively, users may fix significant residues by checking the corresponding box in the "statistics" tab to the left of the pLogo.
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Current Protocols in Chemical Biology 7. The zoom can be changed by clicking the "customize" tab, and either hitting the ± buttons, or entering a value. Clicking "renormalize" will rescale the pLogo back to its default size.
For additional functionality and explanations, see:
O'Shea JP, Chou MF, Quader SA, Ryan JK, Church GM, & Schwartz D. (2013) . pLogo: A probabilistic approach to visualizing sequence motifs. Nat Methods 10, 1211-1212.
REAGENTS AND SOLUTIONS
Desalting elution solution (50 ml)
Combine the following into a 50-ml Pyrex medium bottle: no. PI78420) 100 µl of 100 mM phenylmethylsulfonyl fluoride (MP Biomedicals, cat. no.
195381) Water, HPLC or LC/MS grade (Fisher Scientific, cat. no. W6-1) Add Tris·Cl, NaCl, and urea into a clean 15-ml conical tube. Add water to approximately 9.5 ml and mix thoroughly. Add protease and phosphatase
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Current Protocols in Chemical Biology inhibitors, and PMSF immediately prior to use. Add water to bring to 10 ml final volume, and store at room temperature. Make buffer fresh daily.
Pro-Q Diamond destain solution (1 liter)
Combine the following in a 1-liter Pyrex medium bottle: 750 ml water (double distilled or Ultrapure) 200 ml acetonitrile, ACS grade (Fisher Scientific, cat. no. A21-4) 100 ml of 1 M sodium acetate (pH 4.0) (Fisher Scientific, cat. no. S210-500) Mix thoroughly Store up to 1 year at room temperature SDS-PAGE gel 12% separating gel 3.4 ml water (double distilled or Ultrapure) 4 ml Bis/Acrylamide (37.5:1) (Bio-Rad, cat. no. 1610158) 2 ml of 1.87 M Tris·Cl (pH 8.9) (Sigma Aldrich, cat. no. T6066) 100 µl of 10% SDS Solution (Fisher Scientific, cat. no. BP166-500) 5 µl TEMED (Fisher Scientific, cat. no. BP150·20) 0.5 ml ammonium persulfate (15 mg/ml solution) (Fisher Scientific, cat. no.
BP179-100)
3.5% Stacking Gel 0.826 ml water (double distilled or Ultrapure) 0.232 ml Bis/Acrylamide (Bio-Rad, cat. no. 1610158) 0.4 ml of 0.312 M Tris·Cl (pH 6.7) (Sigma Aldrich, cat. no. T6066) 20 µl of 10% SDS Solution (Fisher Scientific, cat. no. BP166-500) 1 µl TEMED (Fisher Scientific, cat. no. BP150-20) 0.533 ml ammonium persulfate (15 mg/ml solution) (Fisher Scientific, cat. no.
Assemble gel casting stand (Bio-Rad, cat. no. 1658050) and plates (glass short plates, Bio-Rad, cat. no. 1653308; 1.5-mn glass spacer plate, Bio-Rad, cat. no. 1653312). Mix separating gel reagents gently (avoid introducing bubbles), and pour separating gel until the level reaches approximately 1-in. below the top of the cassette. Layer isobutanol (use a 1:1 ratio of isobutanol:water, and use only the top, less dense layer) on top of the separating gel to prevent bubbles and level the gel. Allow the gel to polymerize for ß30 min. Pour off isobutanol and rinse with water. Mix stacking gel reagents gently (avoid introducing bubbles), and pour stacking gel to the top of the cassette. Insert an appropriate comb (e.g., 10-well; Bio-Rad, cat. no. 1653365 or 15-well comb; Bio-Rad, cat. no. 1653366) and allow the gel to polymerize for approximately 30 min. Gels can be wrapped in plastic wrap and stored up to several days at 4°C.
SDS-PAGE running buffer, 10×
30 g Tris base (Sigma Aldrich, cat. no. T6066) 144 g glycine (Fisher Scientific, cat. no. BP381-1) 10 g SDS (Fisher Scientific, cat. no. BP166-500) Water (double distilled or Ultrapure) Add reagents and water to a final volume of 1 liter, and mix thoroughly. It is not necessary to adjust the pH (which should be pH 8.3). Store up to 1 year at room temperature.
TiO 2 binding solution (100 ml)
Combine the following in a 100-ml Pyrex medium bottle: continued 33.44 ml water, HPLC or LC/MS grade (Fisher Scientific, cat. no. W6-1) 50 ml acetonitrile, LC/MS grade (Fisher Scientific, cat. no. A955-1) 16.56 ml lactic acid (Sigma Aldrich, cat. no. 69785-1L) Mix thoroughly Store up to 1 year at room temperature The lactic acid makes the solution very sticky. Gloves exposed to TiO 2 binding solution may stick to tubes.
TiO 2 elution solution (50 ml)
0.34 g KH 2 PO 4 (potassium phosphate monobasic; Fisher Scientific, cat. no. BP362-500) Water, HPLC or LC/MS grade (Fisher Scientific, cat. no. W6-1) Add dry reagents in a 50-ml Pyrex medium bottle. Add water to ß45 ml and mix thoroughly. Adjust pH to 10 with NaOH. Add water to bring to 50 ml final volume, mix thoroughly, and store up to 1 year at room temperature.
COMMENTARY Background Information
There are several existing strategies for determining kinase specificity motifs. The simplest approach is to align experimentally determined phosphorylation sites for a given kinase on the phosphoacceptor, and extract motifs bioinformatically. However, due to the complex, overlapping nature of kinase signaling cascades, it has been difficult to unambiguously pair identified phosphorylation sites with their upstream kinase. As a result of this bottleneck, several strategies have been developed for determining protein kinase substrate specificity motifs. Early success came from the use of an oriented peptide library, in a strategy pioneered by Cantley and colleagues (Songyang et al., 1994) . This method utilized a synthetic peptide library of ࣙ2.5 billion distinct sequences, which all contained a single phosphoacceptor in the center of the peptide flanked by 4 variable positions upstream and downstream, and linker residues at the termini. The kinase of interest was incubated with the library and 32 P-ATP in an in vitro kinase reaction. Phosphopeptides were then separated by ferric iminodiacetic acid, and sequenced by Edman degradation. Observed residue frequencies in each position were compared to their respective abundance (obtained by sequencing the peptide library) to identify important determinants. While successful, this approach has several drawbacks. Notably, identification by Edman degradation is laborious and time-consuming, and technical limitations prevent querying tryptophan or cysteine (which interfere with sequencing due to oxidation), or additional phosphoacceptors (which would render the phosphorylation site ambiguous). In order to eliminate these challenges, the technique was refined by Turk and colleagues to a matrix format. Peptide libraries are arranged in a grid, with a single fixed residue/position for each well (representing all the possible amino acids in each position), while the other positions are randomized. After incubation with the kinase and 32 P-ATP, the reactions are spotted onto a membrane, and phosphorylation preferences are read by measuring radioactive incorporation at different fixed residue positions (Hutti et al., 2004) . While these methods provide a wealth of data, the combinatorial libraries are prohibitively expensive for most labs. Additionally, they require the use of radioactivity and large amounts of recombinant kinase. Importantly, these approaches use peptide substrates (which are less physiologically relevant than protein substrates), and there is no ability to discern correlation between motif positions.
The next milestone came with the utilization of depleted cell lysates, which could function as a proteomic library. Crucially, a proteomic library (unlike a random library) is amenable to sequencing by tandem mass spectrometry. This approach was first demonstrated by Huang and colleagues (Huang, Tsai, Chen, Wu, & Chen, 2007) , wherein rat uterus homogenate was fractionated by Strong Anion Exchange (SAX), treated with phosphatases (to remove endogenous phosphorylation), and heated to inactivate endogenous kinases and all phosphatases. The resulting fractions were incubated with recombinant kinase and cold ATP to allow the kinase of interest to phosphorylate the depleted cellular protein fractions (in the absence of 32 P-ATP). The reaction mixture was digested with trypsin and phosphoenriched by IMAC, Lubner et al.
of 23
Current Protocols in Chemical Biology followed by identification by tandem mass spectrometry. Other versions of this approach inactivated endogenous kinases by tryptic digestion prior to SCX fractionation and dephosphorylation (Kettenbach et al., 2012) or by the addition of the irreversible ATP-competitive analog 5 -4-fluorosulphonylbenzoyladenosine (FSBA) (Knight et al., 2012) . While the use of a proteomic library (and therefore the ability to identify sites by tandem mass spectrometry) is a significant advantage, these methods still require large amounts of recombinant kinase, run the risk of contamination in the event of incomplete dephosphorylation or residual endogenous kinase activity, and in some cases require that specificity preferences be queried by peptide (rather than protein) substrates.
The ProPeL approach described in this article has several important benefits and advantages over existing strategies. As the phosphorylation reactions occur in vivo in the E. coli cytoplasm, the living host produces both the kinase and substrate proteins, and regulates the environment (pH, ionic and co-factor concentrations, etc.). This obviates the need to purify catalytically active kinase, and means that the target kinase interacts with substrates under conditions that are more physiologically relevant than an in vitro reaction. The substrates themselves are full-length E. coli proteins, which offer two distinct advantages. First, the kinase reaction occurs with phosphoacceptors within protein substrates that are able to adopt a physiologically appropriate folded structure, rather than peptides that may not fully recapitulate the environment surrounding the phosphoacceptor. Second, a proteomic background allows unambiguous sequence and site identification using tandem mass spectrometry. This not only allows for high-throughput sequencing, but also puts each phosphorylation site in sequence context, which allows for intramotif correlation between positions. As direct phosphorylation of bacterial substrates by the kinase of interest is measured, there is no need for radioactive material (typically 32 P-ATP), making ProPeL safer than traditional approaches. The actual reaction and sample preparation are also significantly cheaper than combinatorial peptide library approaches, although access to a mass spectrometer is required.
Critical Parameters
The success of a ProPeL experiment crucially depends on the ability to express soluble, active kinase to facilitate the in vivo phosphorylation of bacterial substrates. While the majority of eukaryotic proteins expressed in E. coli were easily purified in their correctly folded state (Braun et al., 2002) , there are several factors that can affect heterologous protein expression (Dyson, Shadbolt, Vincent, Perera, & McCafferty, 2004) . It is reasonable to expect that expressing different foreign kinases within E. coli will lead to differential exogenous phosphorylation, necessitating different optimal expression conditions to maximize in vivo phosphorylation of bacterial substrates by each kinase. There are several variables that can be adjusted to improve in vivo expression and activity.
Choosing the correct E. coli cell strain
In our hands, the single variable that has impacted target kinase expression the most has been selecting the correct cell strain. E. coli expression of the 61 tRNAs is different from eukaryotic species, which can hinder heterologous protein expression for transcripts that are rich in codons that are under-utilized in E. coli (Kane, 1995) . This can be ameliorated by exhaustive codon optimization of the target kinase coding sequence, or by the usage of so-called codon-optimized strains. For example, the Rosetta2 strains supply tRNAs for the codons AUA, AGG, AGA, CUA, CCC, GGA, and CGG. Over-expression of these tRNAs can improve expression of the target kinase.
Alternatively, expression of the target kinase may be cytotoxic, preventing any cells that are competent to express the protein from surviving. A commonly used strategy is to switch to a resistant host strain, such as the C41(DE3) and C43(DE3) "Walker" strains, which exhibit elevated ability to express membrane-bound and toxic proteins (Miroux & Walker, 1996) . These strains were later characterized as having mutations in the lacUV5 promoter (which controls expression of T7 RNA polymerase) and therefore exhibited more gradual target protein expression (Wagner et al., 2008) .
Typically, we start by expressing a new plasmid in both C41(DE3) and Rosetta2 cells. If the target kinase expresses in the C41(DE3) strain, it implies that codon usage is not a concern, and typically we observe more robust expression in C41(DE3) strains than in Rosetta2. However, when codon utilization appears to be an issue, expression is often only successful in Rosetta2, with no expression in C41(DE3). We have also begun to use C43(DE3) cells with some success for kinases that failed to express in C41(DE3).
Protein induction and growth conditions
Protein expression is commonly achieved using the inducible T7 promoter pET system, whereby induction is initiated by addition of an allolactose analog, usually isopropyl β-D-1-thiogalactopyranoside (IPTG) (Donovan, Robinson, & Glick, 1996) . Controlling the concentration of IPTG used and the temperature and duration of induction is critical for optimizing target kinase expression. Typical IPTG concentrations range from 0.1 to 1 mM, and while increasing concentrations can lead to faster protein production, this has the danger of overwhelming the cells and causing cytotoxicity. Similarly, while a longer induction may allow more time for kinase expression, this can be detrimental if the kinase hinders growth.
While IPTG induction is very successful in many instances, induction may overwhelm the cell, inhibiting further protein expression and in some cases killing plasmid-bearing cells.
As an alternative to IPTG induction, protein expression can be accomplished using the autoinduction system, which uses a complex media containing both glucose and lactose. The E. coli preferentially metabolizes the glucose, growing to high density while target protein expression is suppressed by glucose. As the glucose is depleted the cells switch to lactose, producing allolactose, and inducing target protein expression in robust, high density cultures (Studier, 2005) .
Enhancing protein solubility
ProPeL relies upon the ability of the target kinase to phosphorylate bacterial proteins in vivo. Therefore, it is critical that the kinase is not only expressed, but is also soluble during expression. The major challenge is to prevent the over-expressed kinase from being sequestered in inclusion bodiesinsoluble aggregates of mis-folded proteins (Schein, 1989) . Inclusion bodies form when exposed, hydrophobic stretches of insoluble, mis-folded, or partially folded proteins stick together via intermolecular β-sheet structures (Fink, 1998) . The dynamics of inclusion body formation are such that there are typically a small number of inclusion bodies seeded by an incorrectly folded protein intermediate. Although various studies have suggested refolding strategies both in vivo (Zhao et al., 2012) and in vitro (Santos et al., 2012) , the consensus is that it is critical to prevent inclusion body formation from ever occurring to maximize yield (Fink, 1998; Schein, 1989) .
Within the context of ProPeL, there are several strategies that can be attempted for increasing solubility. At the start of a new ProPeL project, it is important to design the correct insert. Reducing the size of the target kinase by only expressing the catalytic domain (if appropriate) will help increase solubility, as lower molecular weight proteins tend to exhibit superior soluble expression (Dyson et al., 2004) . The addition of fusion-protein tags such as 6XHis, GST, and MBP may also increase solubility, although there are no universal rules for how a tag may help or hinder solubility, and the inclusion of a tag may interfere with kinase function (Guerrero, Ciragan, & Iwaï, 2015; Rosano & Ceccarelli, 2014) . Lowering the temperature during induction has also been demonstrated to improve protein solubility (Baldwin, 1986) . Finally, co-expressing the target protein with molecular chaperones such as the GroELS or DnaK system is a common strategy to aide protein folding (Nishihara, Kanemori, Yanagi, & Yura, 2000; Marco et al., 2007) . Unfortunately, to date this step has provided the most significant challenge for ProPeL, with limited success in the cases of protein kinases that appear insoluble.
Troubleshooting
In troubleshooting in vivo activity, it is advantageous to first identify whether the issue is protein expression, protein solubility, or kinase activity. The first question that must be answered is a relatively simple one: Is the target kinase expressed? Kinase expression is easily evaluated by lysing an aliquot in the standard denaturing lysis buffer and evaluating expression by SDS-PAGE and Coomassie staining. An example of the desired level of kinase expression is provided in Figure 2 . It is also possible to evaluate expression by western blotting, but this may only be necessary if the expected kinase molecular weight is the same as highly expressed endogenous E. coli proteins. If the kinase is not sufficiently expressed as to be easily detected by Coomassie staining, then it is likely not expressed sufficiently to provide adequate in vivo activity. It is also worth noting that expression patterns for endogenous E. coli proteins change with expression conditions, so it is important to run negative controls (i.e., a kinasedead mutant, see Strategic Planning) for each expression condition to generate an accurate background for comparison. If there is no detectable expression, this may indicate one of several problems. Strategies for overcoming codon bias, cytotoxicity, and solubility have Lubner et al.
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Current Protocols in Chemical Biology been discussed above in the Critical Parameters section. Considerations for kinase activation requirements have been discussed in the Strategic Planning section, and should be used to inform the choice between the Basic Protocol and Alternate Protocol.
Anticipated Results
In our experience, the number of unique phosphorylation sites discovered for a particular kinase of interest most strongly correlates with the level of expression and in vivo activity. With the instrumentation setup described in this protocol, we have observed that the total number of unique phosphorylation sites identified in a single run can range from 200 to 500 sites for one kinase to over 1500 sites for a different kinase. Technical replicates significantly increase detected phosphopeptides (Ham et al., 2008) , although in our experience 2 to 3 technical replicates are typically sufficient.
Kinase motifs can at times be highly specific, where precise residue positions are favored, presumably due to the unique steric considerations, angles, and electrostatic properties associated with the individual residues. These motifs are frequently represented as consensus sequences, which offer the idealized version of the motif. A classic example is the PKA motif, which today we can summarize as the consensus sequence [R/K][R/K]x[S/T] , where [R/K] indicates a preference for either arginine or lysine, represents a hydrophobic amino acid, and "x" indicates no preference. While the PKA motif is well-defined, specificity motifs can also be more general, such as simple recognition of charge or hydrophobicity, and with positional flexibility. It is important to consider motif results holistically, allowing for both specific and general preferences when interpreting the pLogo for a given kinase. It is also informative to evaluate phosphoacceptor motifs separatelyoften there can be subtle differences between preferences surrounding serine compared with threonine phosphoacceptors, even for the same kinase.
Time Considerations
The Basic Protocol takes ß1 week to complete on average. Starting with an overnight bacterial starter culture, expression typically takes up to a day. Cell harvesting, lysis, quantification and SDS-PAGE analysis occurs on day 2, and typically takes a full day. The most efficient workflow is to perform a methanol/chloroform extraction at the end of the day, and allow the protein disc to resolubilize overnight. The tryptic digestion should not proceed longer than 16 hr, so we typically begin reduction and alkylation steps around 2 pm on day 3. Tryptic digestion occurs overnight. SEP-Pak peptide desalting, lyophilization, and TiO 2 enrichment can be accomplished in a single day, but we often store lyophilized peptides (pre-TiO 2 ) at −20°C overnight. Analysis by LC-MS/MS takes approximately 4 hr for each run including the BSA QC standard analysis. MaxQuant and Andromeda processing of the raw spectra typically takes approximately 0.5-3 hr, depending on the number of simultaneous searches and number of threads available on the server, while data filtering and pLogo analysis can be completed in under an hour. There are several pause points that are noted throughout the protocol. We have successfully stored cell pellets at −80°C for several months, and have stored lyophilized peptides (pre-TiO 2 ) at −20°C for several months. Cell lysate can be stored at 4°C for several months.
